Sowell Financial Services’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
Other funds holding CHRS
PA
KKRC
ACB
Sowell Financial Services's CHRS Position: Q2 2021 in Review
Sowell Financial Services sold out of Coherus Oncology (CHRS) in Q2 2021, closing a stake of 76 shares — an estimated $1K sold.
Sowell Financial Services first reported a position in CHRS in Q1 2020 and held it in 5 quarters. The position peaked at $22K in Q4 2020. 189 funds tracked by Wall St. Rank hold CHRS as of Q2 2021.
- Sowell Financial Services reported no remaining Coherus Oncology position as of Q2 2021 after selling out during the quarter.
- Sowell Financial Services sold 76 Coherus Oncology shares in Q2 2021, an estimated $1K.
- Sowell Financial Services first reported a position in Coherus Oncology in Q1 2020 and held it in 5 quarters.
- Sowell Financial Services's Coherus Oncology position peaked at $22K in Q4 2020.
- 189 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2021.
Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.